Effects of systemic inflammation on relapse in early breast cancer

Chronic inflammation has been a proposed mechanism of resistance to aromatase inhibitors in breast cancer. Stratifying by HER2 status, a matched case-control study from the Wellness After Breast Cancer-II cohort was performed to assess whether or not elevated serum inflammatory biomarkers (C-Reactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: McAndrew, Nicholas P., Bottalico, Lisa, Mesaros, Clementina, Blair, Ian A., Tsao, Patricia Y., Rosado, Jennifer M., Ganguly, Tapan, Song, Sarah J., Gimotty, Phyllis A., Mao, Jun J., DeMichele, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822844/
https://www.ncbi.nlm.nih.gov/pubmed/33483516
http://dx.doi.org/10.1038/s41523-020-00212-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822844/
https://www.ncbi.nlm.nih.gov/pubmed/33483516
http://dx.doi.org/10.1038/s41523-020-00212-6

Ejemplares similares